STOCK TITAN

Solesence Stock Price, News & Analysis

SLSN Nasdaq

Welcome to our dedicated page for Solesence news (Ticker: SLSN), a resource for investors and traders seeking the latest updates and insights on Solesence stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Solesence's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Solesence's position in the market.

Rhea-AI Summary

Solésence (Nasdaq: SLSN), a healthcare solutions provider specializing in beauty and life science, has announced its upcoming inclusion in both the Russell 3000® and Russell 2000® Indexes, effective June 30, 2025. This milestone follows the company's recent Nasdaq uplisting and is part of the 2025 Russell indexes reconstitution.

The inclusion is based on FTSE Russell's objective market-capitalization rankings, which capture the 4,000 largest US stocks as of April 30. This development is particularly significant as approximately $10.6 trillion in assets are benchmarked against Russell US indexes, potentially increasing Solésence's visibility among institutional investors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Solésence (NASDAQ: SLSN) has expanded its debt facilities through amendments to existing loan agreements, increasing its maximum borrowing capacity from $14.2 million to $23.0 million. The amendments, executed on May 27, 2025, also extend the maturity dates from October 1, 2025 to April 30, 2027. The enhanced financial flexibility will support strategic objectives including raw material procurement at favorable prices, improved packaging and product launch lead times, and increased support for brand partners. CEO Jess Jankowski emphasized that the expanded capacity and extended timeline will help scale operations and better serve brand partners.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.4%
Tags
none
-
Rhea-AI Summary
Solésence (NASDAQ: SLSN) reported strong Q1 2025 financial results with revenue increasing 48% to $14.6 million compared to $9.9 million in Q1 2024. The company achieved record shipment volume, up 95% year-over-year, and increased production volume by 120%. However, gross margin declined to 23% from 36% due to one-time start-up costs related to a new strategic brand partner launch. Net income was breakeven compared to $0.9 million in Q1 2024. The company successfully uplisted to Nasdaq and expanded its intellectual property with new technology patents in Japan, South Korea, and Mexico. Management reported strong order momentum with current shipped and open orders exceeding $45 million, indicating continued sequential revenue growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.74%
Tags
Rhea-AI Summary

Solésence (Nasdaq: SLSN), a leader in scientifically-driven health care solutions focusing on beauty and life science categories, has scheduled its first quarter 2025 financial results announcement and conference call.

Key Details:

  • Results Release: Monday, May 5, 2025, after market close
  • Conference Call Time: 4:00 p.m. CDT / 5:00 p.m. EDT
  • Key Speakers: Jess Jankowski (President & CEO) and Kevin Cureton (Chief Operating Officer)

Participants can access the conference call through multiple channels:

  • Webcast: Available via media server link
  • Dial-in: Registration required for personalized PIN
  • Company Website: Accessible through investor relations page

Interested parties are advised to join the call at least five minutes before the start time. The company has provided convenient registration options, including an automatic dial-out feature once the conference begins.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.85%
Tags
conferences earnings

FAQ

What is the current stock price of Solesence (SLSN)?

The current stock price of Solesence (SLSN) is $3.8 as of July 16, 2025.

What is the market cap of Solesence (SLSN)?

The market cap of Solesence (SLSN) is approximately 265.7M.
Solesence

Nasdaq:SLSN

SLSN Rankings

SLSN Stock Data

265.69M
18.57M
Perfumes, Cosmetics & Other Toilet Preparations
ROMEOVILLE